Beactica AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10875
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction analysis, discovery of non-competitive ligands and allosteric sites among others. It uses SPR-based small molecule drug discovery platform for lead identification and optimization. The company works in strategic collaborations with pharmaceutical companies to develop small molecule therapeutics. Beactica is headquartered in Uppsala, Sweden.

Beactica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Partnerships 12
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Licensing Agreements 16
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB – Key Competitors 17
Beactica AB – Key Employees 18
Beactica AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Nov 06, 2017: Beactica Appoints Erik Wallden and Uli Hacksell to its Board of Directors 20
Government and Public Interest 21
Apr 18, 2018: Beactica wins European Horizon 2020 innovation grant for project targeting aggressive brain tumours 21
Nov 22, 2017: Beactica awarded funding to develop new therapeutics against aggressive brain tumours 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Beactica AB, Pharmaceuticals & Healthcare, Key Facts 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB, Key Competitors 17
Beactica AB, Key Employees 18
Beactica AB, Other Locations 19

List of Figures
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Beactica AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Axion Power International Inc (AXPW):企業の財務・戦略的SWOT分析
    Summary Axion Power International Inc (Axion Power) is an energy equipment manufacturer that manufactures, develops, designs, and sells energy storage components, equipment, and devices. The company's products include batteries, energy storage equipment, advanced energy storage products, PowerCube m …
  • Lees Foods Ltd.:企業の戦略・SWOT・財務情報
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Amarantus Bioscience Holdings Inc:企業のM&A・事業提携・投資動向
    Amarantus Bioscience Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amarantus Bioscience Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • United BioSource Corp-製薬・医療分野:企業M&A・提携分析
    Summary United BioSource Corp (UBC), a subsidiary of Express Scripts Holding Company is a provider of pharmaceutical support services. The company offers medicines and medical products. Its services comprise clinical development and late stage research, risk management and pharmacovigilance, nursing …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Maxim Power Corp. (MXG):企業の財務・戦略的SWOT分析
    Maxim Power Corp. (MXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Helix BioMedix Inc:企業の戦略的SWOT分析
    Helix BioMedix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Sun Pharma Advanced Research Company Ltd (SPARC)-製薬・医療分野:企業M&A・提携分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd is a pharma research and drug discovery company that conducts research and and produces drugs. The company develops active pharmaceutical ingredients, formulations and drug delivery technologi …
  • Volex plc (VLX):企業の財務・戦略的SWOT分析
    Volex plc (VLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • UMW Holdings Bhd (UMW):企業の財務・戦略的SWOT分析
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ryosan Company, Ltd
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Natura Cosmeticos SA:戦略・SWOT・企業財務分析
    Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report Summary Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chongqing Rural Commercial Bank Co., Ltd.:戦略・SWOT・企業財務分析
    Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Super Dragon Technology Co., Ltd. (9955):企業の財務・戦略的SWOT分析
    Super Dragon Technology Co., Ltd. (9955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Becle S.A.B. de C.V. (CUERVO):企業の財務・戦略的SWOT分析
    Becle S.A.B. de C.V. (CUERVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • NanoSmart Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NanoSmart Pharmaceuticals Inc (NanoSmart) focuses on the development of novel methods for the treatment of cancer and other diseases. The company is evaluating a human-derived anti-nuclear antibody which targets areas of necrosis presence in various different types of cancer tumors. Its prop …
  • Verbund AG (VER):電力:M&Aディール及び事業提携情報
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務分析
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Office Depot, Inc.:戦略・SWOT・企業財務分析
    Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆